Epidemiological Study of the Prevalence of Age-Related Macular Degeneration in Portugal

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Association for Innovation and Biomedical Research on Light and Image
ClinicalTrials.gov Identifier:
NCT01298674
First received: February 15, 2011
Last updated: April 4, 2014
Last verified: April 2014
  Purpose

This is an epidemiological study to assess the the prevalence of Age-Related Macular (ARM) Degeneration in Portugal.


Condition
Age-Related Macular Degeneration
Other Ocular Disease Such as: Diabetic Retinopathy, Glaucoma, Cataract, Etc.

Study Type: Observational
Study Design: Observational Model: Ecologic or Community
Time Perspective: Cross-Sectional
Official Title: Epidemiological Study of the Prevalence of Age-Related Macular Degeneration in Portugal

Resource links provided by NLM:


Further study details as provided by Association for Innovation and Biomedical Research on Light and Image:

Primary Outcome Measures:
  • ARM [ Time Frame: 1 month after the screening ] [ Designated as safety issue: Yes ]
    Signs of Age-Related Macular Degeneration


Secondary Outcome Measures:
  • Other ocular disease [ Time Frame: 1 month after screening ] [ Designated as safety issue: Yes ]
    Signs of other ocular disease such as: diabetic retinopathy, glaucoma, cataract, etc.


Estimated Enrollment: 6000
Study Start Date: August 2009
Estimated Study Completion Date: April 2014
Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   55 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Participants with 55 or more years-old

Criteria

Inclusion Criteria:

  • Participants with 55 years-old

Exclusion Criteria:

  • None
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01298674

Locations
Portugal
Health care units of Lousã and Trevim-Sol
Lousã, Coimbra, Portugal, 3200-201
ARS Centro - Centro de Saúde de Mira
Mira, Portugal
Sponsors and Collaborators
Association for Innovation and Biomedical Research on Light and Image
Investigators
Study Director: José Cunha-Vaz, MD, PhD Association for Innovation and Biomedical Research on Light and Image
Principal Investigator: Rufino Silva, MD, PhD Association for Innovation and Biomedical Research on Light and Image
  More Information

No publications provided

Responsible Party: Association for Innovation and Biomedical Research on Light and Image
ClinicalTrials.gov Identifier: NCT01298674     History of Changes
Other Study ID Numbers: CC-01-2009
Study First Received: February 15, 2011
Last Updated: April 4, 2014
Health Authority: Portugal: AIBILI - Comissão de Ética para a Saúde

Additional relevant MeSH terms:
Diabetic Retinopathy
Glaucoma
Macular Degeneration
Retinal Diseases
Cataract
Eye Diseases
Diabetic Angiopathies
Vascular Diseases
Cardiovascular Diseases
Diabetes Complications
Diabetes Mellitus
Endocrine System Diseases
Ocular Hypertension
Retinal Degeneration
Lens Diseases

ClinicalTrials.gov processed this record on September 14, 2014